HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 357 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,898,654 | +7.5% | 102,059 | +1.5% | 0.01% | +16.7% |
| Q2 2023 | $3,625,251 | -2.4% | 100,506 | +3.4% | 0.01% | 0.0% |
| Q1 2023 | $3,713,672 | -24.1% | 97,242 | +13.1% | 0.01% | -33.3% |
| Q4 2022 | $4,890,327 | +67.3% | 85,946 | +16.3% | 0.01% | +50.0% |
| Q3 2022 | $2,923,000 | +119.0% | 73,911 | +143.7% | 0.01% | +200.0% |
| Q2 2022 | $1,335,000 | +5.9% | 30,330 | -4.1% | 0.00% | 0.0% |
| Q1 2022 | $1,261,000 | -0.5% | 31,621 | +0.3% | 0.00% | 0.0% |
| Q4 2021 | $1,267,000 | -3.4% | 31,516 | -2.3% | 0.00% | 0.0% |
| Q3 2021 | $1,311,000 | -8.7% | 32,249 | +2.0% | 0.00% | 0.0% |
| Q2 2021 | $1,436,000 | +19.2% | 31,627 | +9.4% | 0.00% | 0.0% |
| Q1 2021 | $1,205,000 | +20.5% | 28,898 | +23.5% | 0.00% | 0.0% |
| Q4 2020 | $1,000,000 | +40.6% | 23,408 | -13.6% | 0.00% | 0.0% |
| Q3 2020 | $711,000 | +10.7% | 27,100 | +13.2% | 0.00% | +100.0% |
| Q2 2020 | $642,000 | +91.1% | 23,950 | +28.0% | 0.00% | 0.0% |
| Q1 2020 | $336,000 | -8.4% | 18,705 | -9.7% | 0.00% | 0.0% |
| Q4 2019 | $367,000 | – | 20,712 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |